SPPI Deadline: Rosen Law Firm Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Businesswireยท2025-09-21 22:07
Group 1 - A class action lawsuit has been filed on behalf of shareholders who purchased common stock of Spectrum Pharmaceuticals, Inc. between May 12, 2022, and September 22, 2022 [1] - The lead plaintiff process for the lawsuit has been reopened by the Court [1] - Spectrum Pharmaceuticals is described as a biopharmaceutical company focused on acquiring, developing, and commercializing drugs [1]